C07D 207/42
Nitro radicals
C07D207/42 (Nitro radicals) appears on 80 US grants and 45 published applications in this corpus.
Search patents in C07D- Granted patents
- 80
- Published applications
- 45
- Assignees
- 35
- Inventors
- 224
- Latest grant
- 5 Dec 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 6 | 0 |
| 1981 | 4 | 0 |
| 1982 | 5 | 0 |
| 1983 | 5 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 2 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 2 | 0 |
| 1991 | 2 | 0 |
| 1992 | 2 | 0 |
| 1993 | 4 | 0 |
| 1994 | 3 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 2 | 3 |
| 2003 | 3 | 7 |
| 2004 | 3 | 8 |
| 2005 | 3 | 4 |
| 2006 | 4 | 4 |
| 2007 | 2 | 0 |
| 2008 | 3 | 4 |
| 2009 | 2 | 4 |
| 2010 | 0 | 1 |
| 2011 | 3 | 3 |
| 2012 | 2 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 1 | 2 |
| 2017 | 1 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 1 | 1 |
| 2022 | 1 | 1 |
| 2023 | 1 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Substituted cyclohexanes as muscarinic M1 receptor and/or M4 receptor agonists5 Dec 2023US 11,834,407 B2Heptares Therapeutics Limited
- Inhibitors of metallo-beta-lactamases16 Aug 2022US 11,413,272 B2Oxford University Innovation Limited
- Oligopyrroles as antagonists of islet amyloid polypeptide oligomerization21 Sep 2021US 11,124,479 B2New York University
- Compound, organic cation transporter 3 detection agent, and organic cation transporter 3 activity inhibitor29 Aug 2017US 9,745,274 B2Shin Nippon Biomedical Laboratories, Ltd.
- Process for the preparation of N,N-dicyclopropyl-4-(1,5-dimethyl-1H-pyrazol-3-ylamino)-6-ethyl-1-methyl-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamide13 Dec 2016US 9,518,058 B2Bristol-Myers Squibb Company
- Lipid compound and composition for delivery of active substance2 Jul 2026US 2026/0184669 A1Korea Research Institute of Bioscience and Biotechnology
- Substituted cyclohexanes as muscarinic m1 receptor and/or m4 receptor agonists7 Jul 2022US 2022/0213034 A1Heptares Therapeutics Limited
- Inhibitors of metallo-beta-lactamases13 May 2021US 2021/0137884 A1Oxford University Innovation Limited
- Oligopyrroles as antagonists of islet amyloid polypeptide oligomerization17 Jan 2019US 2019/0016679 A1New York University
- Novel Compound, Organic Cation Transporter 3 Detection Agent, And Organic Cation Transporter 3 Activity Inhibitor3 Nov 2016US 2016/0318886 A1Shin Nippon Biomedical Laboratories, Ltd.
Most cited
By later US patents
- Isoquinoline compounds having antiinfective activity117US 6,777,425 B2GeneSoft Pharmaceuticals, Inc. · 2004
- Benzothiophene compounds having antiinfective activity82US 7,329,765 B2GeneSoft Pharmaceuticals, Inc. · 2008
- Antipathogenic benzamide compounds82US 7,348,427 B2GeneSoft Pharmaceuticals, Inc. · 2008
- Arylpyrrole insecticidal acaricidal and nematicidal agents and methods for the preparation thereof75US 5,010,098 AAmerican Cyanamid Company · 1991
- Prodrugs of biologically active hydroxyaromatic compounds67US 5,001,115 AUniversity of Florida · 1991